Company / Operating Margin
ANI Pharmaceuticals, Inc. Operating Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
12.6%
FY2025
5-year range
-18.4% / 12.6%
FY2021-FY2025
Trend
+12480.0%
vs FY2024
Sector context
#37 of 136
Health Care
What the data says
Operating Margin changed +12480% YoY in FY2025, a notable deviation from the 9-year average annual change of +1381%.
Based on SEC 10-K filings.
12.6% in FY2025 with a 5-year CAGR of +20.3%.
Improved from 9.7% to 12.6% over the past 2 years.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- +23.7pp
- 5-Year Change
- +20.3pp
- 10-Year Change
- -
Sector benchmark
#37 of 136 in Health CareTop 27% of 136This company 12.6% Sector average -778.9%
▼
+101.6% above sector average
Key checks
Key Insights
- In FY2025, operating margin increased 12480.0% year-over-year.
- Currently 791.5pp above the Health Care sector average.
- Peak operating margin was recorded in FY2019.
- Lowest operating margin in the period was in FY2021.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 12.6% | +12480.0% |
| FY2024 | 0.1% | -99.0% |
| FY2023 | 9.7% | +186.5% |
| FY2022 | -11.2% | +39.4% |
| FY2021 | -18.4% | -139.7% |
| FY2020 | -7.7% | -124.8% |
| FY2019 | 30.9% | +76.3% |
| FY2018 | 17.5% | +9.5% |
| FY2017 | 16.0% | +2.6% |
| FY2016 | 15.6% | +422.1% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026